IBRX Quarterly Accounts Receivable
$4.17 M
+$3.14 M+304.16%
30 September 2024
Summary:
As of January 23, 2025, IBRX quarterly accounts receivable is $4.17 million, with the most recent change of +$3.14 million (+304.16%) on September 30, 2024. Over the past year, it has increased by +$3.14 million (+304.16%). IBRX quarterly accounts receivable is now at all-time high.IBRX Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IBRX Accounts Receivable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | +304.2% |
| 3 y3 years | - | - |
| 5 y5 years | - | - |
IBRX Accounts Receivable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +304.2% | ||
| 5 y | 5-year | at high | +304.2% | ||
| alltime | all time | at high | +304.2% |
ImmunityBio Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $4.17 M(+304.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2024 | - | $1.03 M |
FAQ
- What is ImmunityBio quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for ImmunityBio?
- What is ImmunityBio quarterly accounts receivable year-on-year change?
What is ImmunityBio quarterly accounts receivable?
The current quarterly accounts receivable of IBRX is $4.17 M
What is the all time high quarterly accounts receivable for ImmunityBio?
ImmunityBio all-time high quarterly accounts receivable is $4.17 M
What is ImmunityBio quarterly accounts receivable year-on-year change?
Over the past year, IBRX quarterly accounts receivable has changed by +$3.14 M (+304.16%)